Researchers
at the University of Nebraska Medical Center have received a five-year
grant for $10 million to continue work on a project to fight the growing
threat of methicillin-resistant
Staphylococcus aureus (MRSA).
MRSA,
a bacterium resistant to many antibiotics, is a big problem in
hospitals and can cause wound infections to more invasive diseases. In
2011, about 721,800 health-care
associated infections occurred in 648,000 hospital patients, according
to the U.S. Centers for Disease Control and Prevention. About 75,000
patients died during their hospitalizations.
Ken
Bayles, Ph.D., principal investigator of the program project grant,
said he and his team are working on four projects first funded in 2009
by the National Institutes
of Health National Institute of Allergy and Infectious Diseases.
Projects will focus on biofilms produced by
Staphylococcus aureus
and understanding their role in causing infections of artificial
devices. Biofilm is a natural biologic material that grows on surfaces
-- like the plaque on teeth before brushing.
“Biofilm can affect
any manmade device that is implanted into our bodies,”
Dr. Bayles said. “With more and more people getting implanted devices,
including stents, pacemakers, catheters, orthopedic devices like knee
and hip replacements, all are
targets for staph infections.”
It
is estimated that the rate of infection of implanted devices is between
1 and 5 percent. He said infections happen in medical devices usually
through contamination
of the surgical wound.
“Getting
rid of biofilm associated with implanted devices is difficult because
biofilm bacteria are resistant to the antibiotics used to treat
infections,” Dr. Bayles
said.
If
antibiotics don't work, the device will need to be removed, followed by
extensive antibiotic treatment, and then replacement with a new device.
It’s traumatic for the
patient and adds a significant burden to health care costs, he said.
No comments:
Post a Comment